Tolerability of BRAF and MEK inhibitors for metastasized melanoma after intra-class switch: a multicenter, retrospective study
M Salzmann, A Wald, H Stege, C Loquai, L Zimmer… - Cancers, 2023 - mdpi.com
Simple Summary Patients suffering from metastasized melanoma can be treated with three
different combinations of tablets (“targeted therapy”), with similar efficacy but different side …
different combinations of tablets (“targeted therapy”), with similar efficacy but different side …
Editorial on Special Issue “Advances and Novel Treatment Options in Metastatic Melanoma”
A Carè, D Del Bufalo, A Facchiano - Cancers, 2022 - mdpi.com
Investigating mechanisms controlling melanoma setup, development and progression is
currently an extremely hot and rapidly evolving topic. Immunotherapy-and target therapy …
currently an extremely hot and rapidly evolving topic. Immunotherapy-and target therapy …
[PDF][PDF] Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective Study. Cancers 2023, 15, 1426
M Salzmann, A Wald, H Stege, C Loquai, L Zimmer… - 2023 - academia.edu
Targeted therapy with BRAF and MEK inhibitors (BRAFi, MEKi) is one of the mainstays of
melanoma treatment. When dose-limiting toxicity (DLT) is observed, an option represents …
melanoma treatment. When dose-limiting toxicity (DLT) is observed, an option represents …
Severe treatment-induced inflammatory polyarthritis in advanced melanoma patients: 2 case reports
J Lauwyck, M Schreuer, LM de Bellefon… - Melanoma …, 2022 - journals.lww.com
Immune checkpoint inhibitors (ICI) and targeted therapies form the therapeutic mainstay for v-
Raf murine sarcoma viral oncogene homolog B V600-mutated metastatic melanoma. Both …
Raf murine sarcoma viral oncogene homolog B V600-mutated metastatic melanoma. Both …
[PDF][PDF] Editorial on Special Issue “Advances and Novel Treatment Options in Metastatic Melanoma”. Cancers 2022, 14, 707
A Carè, D Del Bufalo, A Facchiano - Advances and Novel Treatment …, 2022 - core.ac.uk
Antonio Facchiano is an oncologist with long lasting experience in the field of new
therapeutics and new diagnostic approaches in melanoma. He published several studies …
therapeutics and new diagnostic approaches in melanoma. He published several studies …